$586 Million is the total value of First Light Asset Management, LLC's 64 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 78.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KRMD | Buy | REPRO-MED SYSTEMS INC | $54,289,000 | +15.2% | 7,238,592 | +0.3% | 9.27% | +53.8% |
| SPNE | Buy | SEASPINE HOLDINGS CORP | $36,680,000 | +67.2% | 4,489,553 | +145.8% | 6.26% | +123.3% |
| IMMU | Buy | IMMUNOMEDICS INC | $27,191,000 | +3.2% | 2,017,103 | +62.0% | 4.64% | +37.8% |
| CDNA | New | CAREDX INC | $23,702,000 | – | 1,085,752 | +100.0% | 4.05% | – |
| PFNX | New | PFENEX INC | $20,636,000 | – | 2,339,671 | +100.0% | 3.52% | – |
| TNDM | Buy | TANDEM DIABETES CARE INC | $18,416,000 | +15.0% | 286,191 | +6.6% | 3.14% | +53.7% |
| XENT | Buy | INTERSECT ENT INC | $17,227,000 | -42.3% | 1,453,729 | +21.2% | 2.94% | -22.9% |
| CDXS | Buy | CODEXIS INC | $16,590,000 | -12.5% | 1,486,598 | +25.3% | 2.83% | +16.8% |
| TEVA | Buy | TEVA PHARMACEUTICAL IND | $16,552,000 | +2.0% | 1,843,246 | +11.3% | 2.83% | +36.2% |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INC | $15,890,000 | – | 530,805 | +100.0% | 2.71% | – |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL INC | $15,222,000 | +104.3% | 342,603 | +96.4% | 2.60% | +173.0% |
| UTHR | New | UNITED THERAPEUTICS CORP DEL | $12,186,000 | – | 128,509 | +100.0% | 2.08% | – |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $11,012,000 | +287.3% | 122,645 | +366.6% | 1.88% | +417.9% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $8,886,000 | +3.5% | 105,157 | +3.6% | 1.52% | +38.3% |
| ZYME | New | ZYMEWORKS INC | $5,140,000 | – | 144,909 | +100.0% | 0.88% | – |
| BLUE | Buy | BLUEBIRD BIO INC | $4,230,000 | -25.4% | 92,047 | +42.5% | 0.72% | -0.3% |
| LGND | Buy | LIGAND PHARMACEUTICALS INC | $3,262,000 | -28.1% | 44,859 | +3.2% | 0.56% | -4.0% |
| AMRN | Buy | AMARIN CORPORATION | $3,032,000 | -69.1% | 757,906 | +65.4% | 0.52% | -58.8% |
| GKOS | New | GLAUKOS CORPORATION | $2,795,000 | – | 90,565 | +100.0% | 0.48% | – |
| ADVM | New | ADVERIUM BIOTECHNOLOGIES INC | $2,367,000 | – | 242,300 | +100.0% | 0.40% | – |
| ITMR | New | ITAMAR MEDICAL LTD | $960,000 | – | 81,500 | +100.0% | 0.16% | – |
| GWPH | New | GW PHARMACEUTICALS PLC | $560,000 | – | 6,400 | +100.0% | 0.10% | – |
| CNC | New | CENTENE CORPORATION | $530,000 | – | 8,917 | +100.0% | 0.09% | – |
| DYNT | Buy | DYNATRONICS CORP | $389,000 | +270.5% | 450,000 | +257.0% | 0.07% | +407.7% |
| LABD | New | DIREXION DAILY S&P BIOTECH BEAR 3X SHARES | $217,000 | – | 15,401 | +100.0% | 0.04% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ATRICURE INC | 40 | Q3 2023 | 9.7% |
| NEOGENOMICS INC | 40 | Q3 2023 | 10.6% |
| SANOFI-SYNTHELABO | 40 | Q3 2023 | 1.9% |
| JOHNSON & JOHNSON | 40 | Q3 2023 | 0.3% |
| PFIZER INC | 39 | Q2 2023 | 0.9% |
| BIOMARIN PHARMACEUTICAL INC | 36 | Q3 2023 | 1.6% |
| OMNICELL INC | 33 | Q3 2023 | 7.7% |
| QUIDEL CORP | 33 | Q4 2021 | 3.7% |
| NOVARTIS AG-SPONSORED ADR | 33 | Q3 2023 | 0.4% |
| MODEL N INC | 30 | Q3 2023 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| REATA PHARMACEUTICALS INC | May 15, 2023 | 1,290,193 | 3.9% |
| Axogen, Inc. | February 03, 2023 | 1,942,270 | 4.6% |
| MODEL N, INC. | February 03, 2023 | 1,845,134 | 4.9% |
| MEI Pharma, Inc.Sold out | May 31, 2022 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | March 01, 2022 | 1,805,038 | 3.9% |
| Intersect ENT, Inc. | February 14, 2022 | 1,375,210 | 4.1% |
| SeaSpine Holdings Corp | February 14, 2022 | 6,847,707 | 18.8% |
| Oxford Immunotec Global PLCSold out | February 10, 2021 | 0 | 0.0% |
| ENDOLOGIX INC /DE/ | February 14, 2020 | 816,236 | 4.6% |
| Nuvectra CorpSold out | February 14, 2020 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13D/A | 2024-04-09 |
| 4 | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.